Min Li, SciNeuro CEO
Eli Lilly seeds a well-connected China neuro startup with drugs aiming at where Biogen, Voyager missed
When Min Li took the wraps off a $100 million round for his Bob Nelsen-backed startup last December — as with most biotech CEOs when they …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.